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Bladder cancer‑related microbiota: 
examining differences in urine 
and tissue samples
Bassel Mansour1, Ádám Monyók1, Nóra Makra2, Márió Gajdács2,3, István Vadnay4, 
Balázs Ligeti2,5, János Juhász2,5, Dóra Szabó2 & Eszter Ostorházi2*
The microbiota isolated from the urine of bladder carcinoma patients exhibits significantly increased 
compositional abundance of some bacterial genera compared to the urine of healthy patients. Our 
aim was to compare the microbiota composition of cancerous tissues and urine samples collected 
from the same set of patients in order to improve the accuracy of diagnostic measures. Tissue samples 
were collected from patients during cancer tissue removal by transurethral resection. In parallel, 
urine samples were obtained by transurethral resectoscopy from the same patients. The V3–V4 
region of the bacterial 16S rRNA gene was sequenced and analyzed using the Kraken pipeline. In 
the case of four patients, duplicate microbiota analysis from distant parts of the cancerous tissues 
was highly reproducible, and independent of the site of tissue collection of any given patient. 
Akkermansia, Bacteroides, Clostridium sensu stricto, Enterobacter and Klebsiella, as “five suspect 
genera”, were over-represented in tissue samples compared to the urine. To our knowledge, this 
is the first study comparing urinary and bladder mucosa-associated microbiota profiles in bladder 
cancer patients. More accurate characterization of changes in microbiota composition during bladder 
cancer progression could provide new opportunities in the development of appropriate screening or 
monitoring methods.
Bladder cancer ranks the ninth most frequently-diagnosed cancer worldwide with 75% cases occurring in  men1. 
While the main risk factor for bladder cancer is tobacco  smoking2, exposure to aromatic  amines3 or environmen-
tal factors such as arsenic in drinking  water4 have been classified as additional carcinogenic risks. In addition, 
genetic factors including slow acetylation of N-acetyltransferase, a key enzyme in aromatic amines metabolism, 
are believed to play roles in bladder cancer  development5.
Urine was traditionally considered sterile; however recent evidence has challenged this dogma by molecular-
based detection of microorganisms in urine of healthy  individuals6. Although the presence of microbes in the 
urinary tract does not necessarily induce infections, some microbial agents do cause acute infection or chronic 
inflammation. On the same token, certain commensal strains may control the overgrowth of pathogenic bacterial 
strains. The association between bladder schistosomiasis infection, inflammation and squamous cell carcinoma 
is well  accepted7, but the role of bacteria in the pathophysiology or management of bladder cancer has not been 
consistently examined. In addition to the genetic characteristics that influence the elimination of chemical car-
cinogens, the processes can be aggravated or attenuated by the presence of biochemically active microbes. For 
example, nitrate producing bacteria can mediate the formation of carcinogenic N-nitrosamines8. Toxins including 
heavy metals, pesticides, ochratoxins, polycyclic aromatic hydrocarbons or other environmental contaminants are 
removed from the bloodstream through renal filtration. All these compounds interact with the microbiota dur-
ing ensuing storage in the bladder. The resulting metabolites can increase or decrease the risk of bladder cancer.
Several factors can influence the difference in incidence and progress of bladder cancer between men and 
women. The study of de Jong et al. described that male hormones may influence the type of bladder cancer that 
a patient  develops9. The urinary microbiota is different in men and  women6. The anatomical and hormonal 
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differences lead not only to higher incidence of female urinary tract infections, but to different compositions 
of urinary microbiota between genders. Incidence of female bladder cancer is significantly lower compared to 
bladder oncogenesis of men. The different microbiota can be one of the hypotheses for the lower incidence of 
bladder cancers in  women10,11.
The urinary microbiota associated with benign urologic conditions from transurethral catheterized urine or 
from voided urine was reviewed in  detail10. In women voided urine samples contained mixtures of urinary and 
genital tract bacteria, however the uncultivated bacteria, assessed by 16S rRNA gene sequencing were common 
in voided, transurethral catheterized or suprapubic aspirated urine  samples12. In men patients with or without 
lower urinary tract symptoms voided urine does not adequately characterize the male bladder microbiota, and 
only the detectable bacteria in catheterized urine were associated to the severity of  symptoms13.
Current knowledge of the microbiota in voided urine or tissue samples of bladder cancer patients is very 
 limited14–17. As far as we know, no studies to date have compared the characteristics of catheterized urine with 
tissue samples in bladder cancer.
Our aim was to determine whether the microbiota composition in samples from different sites of a given 
tumor tissue is consistent and to compare the microbiota isolated from the tumor tissue with that from the urine 
of the same patients.
Results
Using conventional culture methods, no bacteria were detected from the urine of any patient.
From the 39 urine and tissue paired samples collected, 24 samples provided sufficient DNA to meet the 
sequencing quality criteria. The 24 samples analyzed included 10 urine and 14 tissue samples collected from ten 
bladder cancer patients. Based on histological examination, four patients had muscle invasive (MIBC) and six 
patients had non-muscle-invasive (NMIBC) tumors. The male/female ratio was 2:4 in the NMIBC group, and 
3:1 in the MIBC group (Table 1).
A total of 3.2 million valid sequences were obtained, resulting in 1.2 million high-quality reads. Within one 
sample, the median number of reads was 119,268.
Figure 1 shows the observed richness and Shannon diversity at the genus level, comparing the gender and 
sample size groups. Statistically significant differences were found only between the median of genus richness 
and Shannon diversity representing female and male tissue samples. Shannon diversity of female patients’ tran-
surethral catheterized urine samples were lower than that of male patients (not significant).
From two isolated distant pieces of the tumor, microbiota analysis was performed in four patients. Figure 2, 
correlation-based reproducibility measurements of bladder cancer tissue microbiota demonstrate that the micro-
biota analysis results were reproducible, independent of the actual site and highly specific to any given person. 
Pearson correlation coefficients were 0.98–1, and p values were < 0.05. However, at the Principal Component 
Analysis (PCA), Fig. 3 the correlated tissue samples do not cluster with their own urine samples. No regularity 
or tendency was shown regarding dominant microorganisms, there was no rule for how the abundance of genus 
changes between tissue and urine (Fig. 4).
In urine samples, the most abundant phyla detected were Firmicutes with abundance of 33%, followed by 
Proteobacteria (29%), Actinobacteria (23%), Cyanobacteria (7%) and Bacteroidetes (4%). In the tissue samples, 
the order was as follows: Firmicutes (34%), Actinobacteria (23%), Proteobacteria (22%), Bacteroidetes (15%) 
and Cyanobacteria (8%). The most abundant genera in urine samples taken as a whole were Lactobacillus, 
Corynebacterium, Streptococcus and Staphylococcus, with age and gender differences in each samples (Table 2). 
In tissue samples the most abundant genera were Bacteroides, Akkermansia, Klebsiella and Clostridium sensu 
Table 1.  Metadata of patients: MIBC: muscle invasive bladder cancer, NMIBC: non muscle invasive bladder 
cancer.
Patients ID Age Gender Biological characteristic Urine sample ID Tissue sample ID
I01 70 Male MIBC UI1
TI01.1
TI01.2
I02 80 Male MIBC UI2 TI02
I03 79 Male MIBC UI3 TI03
I04 76 Female MIBC UI4 TI04
N01 72 Male NMIBC UN1
TN01.1
TN01.2
N02 54 Male NMIBC UN2
TN02.1
TN02.2
N03 66 Female NMIBC UN3
TN03.1
TN03.2
N04 58 Female NMIBC UN4 TN04
N05 20 Female NMIBC UN5 TN05
N06 64 Female NMIBC UN6 TN06
Summary 63.9 Male/female = 5/5 MIBC/NMIBC = 4/6 10 14 24
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stricto. Akkermansia, Bacteroides, Clostridium sensu stricto, Enterobacter and Klebsiella genera showed remark-
ably higher compositional abundance in tissue than in urine samples (Fig. 5).
The Fig. 6 heat map shows the coexistence of five genera in tissue samples. Clostridium sensu stricto, Akker-
mansia, Bacteroides, Enterobacter and Klebsiella are characteristic but not general for all samples. No relation-
ship was found between the biological characteristic of cancer [muscle invasive bladder cancer (MIBC) versus 
non-muscle invasive bladder cancer (NMIBC)] and microbiota composition.
Discussion
Since there were no significant differences between the richness and Shannon diversity values of the transurethral 
catheterized urine and tissue microbiota, we might even lead to think that a urine microbiota test is suitable as a 
diagnostic and prognostic tool in bladder tumor research. However, the fact that there are significant differences 
between the diversity of female and male tissue samples confirms that transurethral catheterized urine samples 
are not mirror images of the microbiota at the site of the cancer. Clearly, the role of tissue associated bacteria in 
tumor progression has to be addressed in future studies.
In agreement with the results of Bucevic et al.15, Firmicutes was the most common phylum in both our tissue 
and urine samples. Two Chinese study  groups16,17 identified Proteobacteria as the most abundant phylum in 
urine and tissue samples of bladder cancer patients. While none of the earlier reports document Cyanobacteria 
as a significant phylum, in our urine and tissue samples its abundance was 7 and 8%, respectively. Microcystins 
are toxic products of Cyanobacteria that induce hepatocellular cancer and promote migration and invasion 
of colorectal  cancer18,19. Assuming that a change in the gut microbiota also results in a change of the bladder 
microbiota, different geographical locations and dietary patterns may play a role in the increased presence of 
Cyanobacterium in our  samples20,21. Further studies are required to quantify the difference in the amount of 
microcystin-producing species in the urine of bladder cancer patients and controls. Provided that microcystins 
also play a role in the development of bladder cancer, we should consider the individual genetic differences in 
the microcystin detoxification process between cancerous and healthy  people22.
Patients with different urinary tract diseases—neurogenic bladder dysfunction, urgency urinary incontinence 
or interstitial cystitis—reflect altered urinary tract microbiota in contrast to healthy  volunteers23–25. Neverthe-
less, the urinary microbiota of a healthy population is ambiguous, because healthy control participants in the 
relevant studies belonged to different age groups and different genders. Lewis et al.6 propose the existence of a 
core urinary microbiota—a subset of bacteria present at variable abundances within the clean-catch, mid-stream 
voided urine—regardless of age and gender. In the age group of 20–49 years our study was limited to one female 
participant with Gardnerella, Lactobacillus and Streptococcus as the most abundant genera in her urine sample. 
These bacteria belong to the core urinary microbiota according to the Lewis classification. In the urine samples 
of our female age group 50–69 years, in addition to the Peptinophilus, Parvimonas, Streptococcus, Lactobacil-
lus and Fastidiosipila genera belonging to the core, most frequent bacteria observed were Escherichia-Shigella, 
Actinotignum and Williamsia. In the 76 years old female patient (age group 70 +) the most abundant genera, 
namely Streptococcus, Lactobacillus and Corynebacterium, were all members of the core. The most common 
Figure 1.  Observed richness and Shannon diversity at genus level from the urine and tissue samples obtained 
from patients: significant difference was shown only between the median of genus richness and Shannon 
diversity of female and male tissue samples.
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genera in urine of our male patients, regardless of age, was Anaerococcus, Corynebacterium, Peptoniphilus, and 
Staphylococcus, genera belonging to the core and Streptococcus outside of the core.
When compared the urine of 6 healthy individuals with 8 patients of urothelial cancer, Xu et al.14, observed 
the enrichment of Streptococcus in the urine from patients with urothelial carcinoma. In contrast, when Bucevic 
et al.15 analyzed 11 healthy and 12 patients with bladder cancer, the most abundant genera in healthy patients’ 
urine were Streptococcus, Veillonella and Corynebacterium, however Fusobacterium, Actinobaculum, Facklamia 
and Campylobacter genera enrichment representing the urine of bladder cancer patients. In the urine of our 
patients Streptococcus, Corynebacterium and Fusobacterium genera were similarly enriched. Wu et al.16 found 
significantly higher relative levels of Acinetobacter, Anaerococcus, Rubrobacter, Sphingobacterium, Atoposites and 
Geobacillus in urine of cancer patients. While in our patients the abundances of Acinetobacter and Anaerococcus 
increased depending on the age and gender group, the other four genera occurred only in minor quantities. Inter-
individual variability was observed between urinary microbiotas of the participants in our study. Having said that, 
the most abundant genera in our samples were those detected by earlier reports. When differences were found, 
the reason for the alterations may be the low number of samples, ethnicity, gender and/or age. In addition, we 
collected the urine directly from the bladder by resectoscopy and not by the clean-catch voided urine method.
Inter-individual variability was observed among the microbiota of tissue samples. However, 5 genera, Akker-
mansia, Bacteroides, Clostridium sensu stricto, Enterobacter and Klebsiella were over-represented in tissue samples 
compared to the urine. This difference indicates that these genera are directly associated with the tissue and 
further studies with larger sample sizes of cancerous bladder mucosa and adjacent normal healthy tissues are 
needed to clarify the genera associated with the oncogenic transformation process. For now, it is impossible to 
determine whether the high abundance of these genera is the cause or consequence of tumorigenesis. The link 
Figure 2.  Correlation-based reproducibility of the microbiota from bladder cancer tissue: Scatter plots A, B, 
C and D show the abundance of genera taken from site 1 and site 2 of a subject (TN01, TN02, TN03, TI01). 
Pearson correlations were calculated for all the 4 subjects. All correlations show strong statistical significance.
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Figure 3.  Principal component analysis (PCA) of correlated bladder cancer tissue samples with their respective 
urine samples: correlated tissue samples did not cluster with their respective urine samples.
Figure 4.  Distribution of genera in the microbiota of the urine and tissue samples obtained from the same 
patients. Each bar represents the microbiota results from the indicated patient, the most abundant genera are 
shown on the left and right sides from tissue and urine samples, respectively.
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between chronic inflammation, microbiota and the progression of solid tumors has been established especially 
for colorectal cancer (CRC). In the CRC animal experiments of Baxter et al.26, the taxa Bacteroides and Akker-
mansia were strongly positively correlated with an increased tumor burden, but Clostridium was associated with 
a decreased rate of malignant transformation. Bacteroides and Akkermansia both are known mucin degraders, 
they undermine the integrity of the mucosal barrier, leading to increased  inflammation27,28. The different species 
from Clostridium genera play different roles in carcinogenesis. The butyrate-producing Clostridium spp. inhibits 
intestinal tumor  development29 as much as Clostridium septicum does not appear to initiate carcinogenesis but 
appears to have a symbiotic relationship with the growth of already developing  malignancies30. The study of 
Yurdakul et al. shows that Enterobacter spp. may be a clinically important factor for colon cancer initiation and 
progression due to apoptosis  inhibition31. The colibactin toxin produced by Klebsiella pneumonia is known to 
cause DNA double-strand breaks inducing genomic instability as well as cell cycle  arrest32. The continuous insult 
of colibactin toxin is supplemented with the influx of proinflammatory cytokines into the colonic microenviron-
ment in the presence of Klebsiella, leads to chronic inflammation, and stimulation of epithelial cell  proliferation33. 
The strong correlation between the appearance of these “five suspect genera” in our samples suggests that this set 
of bacteria mutually enhances each other’s carcinogenic effects. Fusobacterial DNA has been detected in pan-
creatic, esophageal or colorectal  cancers34,35. Bucevic et al.15 detected Fusobacterium in 25% of urine samples of 
bladder cancer patients. None of our tissue samples contained Fusobacterium DNA at the level of detection, but 
it was represented in all our urine samples. Liu et al. found a higher abundance of Cupriavidus, Acinetobacter, 
Anoxybacillus, Escherichia–Shigella, Geobacillus, Pelomonas, Ralstonia and Sphingomonas genera in the cancer-
ous relative to healthy tissues of the same bladder cancer  patients17. In our study Cupriavidus and Pelomonas 
were represented only in tissue samples; the urine of these two patients did not contain any detectable amount 
of these genera. Acinetobacter, Anoxybacillus, Escherichia-Shigella, Geobacillus, Ralstonia and Sphingomonas were 
increasingly represented in our tissue samples compared to the urine samples. The fact that these latter genera, 
and our “five suspects” are detectable in greater quantities in cancerous tissue than in the urine supports the 
hypothesis that these bacteria were associated with the tumor-altered tissue.
The small number of patients (5 male and 5 female) is a limitation of this study, and restricts the conclusions 
that may be drawn on the impact of gender differences on microbiota changes in bladder cancer development. 
Additional, more exhaustive studies are required to obtain increasingly accurate data for the better understand-
ing of cause-effect relationships between microbiota and bladder cancer.
Tumor tissue size limited the ability to perform microbiota analysis in duplicate from each tissue sample.
Using the 16S rRNA sequencing method, analyzed by the Kraken-Bracken pipeline is not validated to infer 
taxonomic information below the genus level, therefore future studies may harness species-level analysis to 
identify specific microbes which may have associations with bladder cancer.
Limitation of the study is that without using samples of healthy controls—due to obvious ethical reasons—it 
is not yet clear whether the „five suspect bacterial genus” are associated exclusively with bladder cancer tissue.
However, this is the first report that evaluates urine samples directly from the bladder, avoiding urethra 
contamination. Moreover, our study suggests that the bladder-mucosa associated microbiota is different from 
Table 2.  The most abundant bacterial genera in urine samples by ages and gender of patients. Those 
highlighted in bold are not members of CORE bacteria in healthy population according to Lewis et al.11.
Age group Female Male
20–49 years
Akkermansia
Atopobium
Bifidobacterium
Gardnerella
Gemella
Lactobacillus
Romboutsia
Staphylococcus
Streptococcus
Turicibacter
No patient in the study
50–69 years
Actinotignum
Enterobacter
Escherichia-Shigella
Fastidiosipilia
Lactobacillus
Neisseria
Parvimonas
Peptoniphilus
Streptococcus
Williamsia
Anaerococcus
Corynebacterium
Fastidiosipila
Lautropia
Peptoniphilus
Porphyromonas
Prevotella
Staphylococcus
Streptococcus
Varibaculum
70 + years
Acinetobacter
Actinomyces
Corynebacterium
Fusobacterium
Lactobacillus
Massilia
Pseudomonas
Sphingomonas
Staphylococcus
Streptococcus
Anaerococcus
Bacillus
Brevundimonas
Corynebacterium
Deinococcus
Lactobacillus
Peptoniphillus
Rubellimicrobium
Staphylococcus
Streptococcus
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the urinary microbiota and provides the best test sample to characterize the association between bacteria and 
carcinogenesis.
Herein, we profiled the bladder mucosa microbiota compared to the urinary microbiota associated with 
bladder cancer in the most comprehensive study to date. Our study reflected that urine samples provide differ-
ent results relative to tissue samples during the characterization of the bacteria involved in carcinogenesis. An 
extension and deepening of these investigations lead to a better understanding of the pathogenesis of bladder 
cancer, and will provide novel diagnostic and therapeutic options.
Methods
Ethics approval and consent to participate. Sample collection protocols were approved by the Ethics 
Committee of Markhot Ferenc University Teaching Hospital (MFUTH) and the Ethics Committee of Semmel-
weis University (SE RKEB: 100/2018). The present study was conducted in accordance with ethical standards 
that promote and ensure respect and integrity for all human subjects and the Declaration of Helsinki. Patients 
treated at the MFUTH’s Urology Department between May and October 2018 were enrolled in this study, all 
research was performed in accordance with guideline and regulation of MFUTH, and written informed consent 
was obtained from all patients.
Sample collection. The study included five male and five female patients with bladder carcinoma. Exclu-
sion criteria were antibiotic or probiotic treatment 2 weeks prior to surgery or recent urinary infection. The 
Figure 5.  Comparative analysis of median fraction total reads at level of genera detected from the microbiota of 
the urine and tissue samples obtained from patients.
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patients’ clinical parameters, and the metadata of the samples are presented in Table 1. Mucosal tissue samples 
removed during transurethral resection (TUR) were divided to histological and microbiota analysis. Urine sam-
ples were collected directly from the bladder during the TUR surgery and divided for traditional routine culture 
and microbiota analysis. Routine urine culture involves inoculation of 10 µl of urine on to blood and eosin-
methylene blue agar plates, and 24-h incubation under ambient atmospheric conditions. The level of detection is 
100 colony-forming units per milliliter (CFU/ml). Fractions for microbiota analysis were centrifuged at 16,000 g 
for 10 min, supernatants were aliquoted and stored at − 80 °C.
DNA isolation, 16S rRNA gene library preparation and MiSeq sequencing. DNA isolation was 
performed by ZymoBIOMICS DNA Miniprep Kit (Zymo Research Corp., Irvine, USA) according to manufac-
turer’s instructions after enzymatic dissolution with ProtK (56 °C, 3 h) for the tissue samples. Enzymatic diges-
tion was performed with standardized 2 mm in diameter tissue pieces.
Concentration of genomic DNA was measured using a Qubit2.0 Fluorometer with Qubit dsDNA HS Assay 
Kit (Thermo Fisher Scientific, Waltham, MA, USA). Bacterial DNA was amplified with tagged primers cover-
ing the V3–V4 region of bacterial 16S rRNA gene. PCR and DNA purifications were performed according to 
Illumina’s protocol. PCR product libraries were assessed using DNA 1000 Kit with Agilent 2100 Bioanalyzer 
(Agilent Technologies, Waldbronn, Germany). Equimolar concentrations of libraries were pooled and sequenced 
on an Illumina MiSeq platform (Illumina, San Diego, CA, USA) using MiSeq Reagent Kit v3 (600 cycles PE).
In order to evaluate contribution of extraneous DNA from reagents, extraction negative controls and PCR 
negative controls were included in every run. To ensure reproducibility, each urine sample was independently 
extracted and sequenced twice. The full tissue samples of four patients were larger than 10 mm in diameter. 
Figure 6.  Heat-map of the distribution of co-existing genera in cancer tissue samples obtained from NMIBC 
(with TN designation) and MIBC (with TI designation) patients. Evidence of a correlation between the 
biological characteristics of the tumor and the distribution of the bacteria is not confirmed. Regardless of 
the biological characteristics of the tumor the co-existence of 5 genera (namely Clostridium sensu stricto, 
Akkermansia, Bacteroides, Enterobacter and Klebsiella) in tissue samples is characteristic.
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These samples were cut into small pieces, two pieces originally located in a distance were separately digested 
enzymatically. All ensuing analytical steps, including the isolation of DNA, PCR, library preparation, sequencing 
and analysis procedures were done in duplicate.
Isolated DNA samples were placed at − 80 °C until PCR amplification.
Raw sequencing data were retrieved from the Illumina BaseSpace. Quality control (QC) of raw reads was 
carried out by FastQC and  MultiQC36. After QC, low quality reads were trimmed by  Trimmomatic37. The first 12 
base pairs and consecutive low base calls were removed (phred score < 20) and only reads with minimal length 
of 36 were kept. The SSU Ref NR 99 database, downloaded on 22/03/2019 (release 132) of SILVA was  used38. 
This contains non-redundant sequences (identity threshold: 99%). The database fasta file was pre-processed and 
indexed by the  Kraken239 tool (kraken2-build) with k-mer = 31. Kraken2 aligned and classified short-reads and 
the final estimation of taxon abundances in various taxonomic levels was performed with  Bracken40.
Richness (number of unique taxa in the sample) and Shannon index (quantifying entropy of the distribution 
of taxa proportions) were used to quantify alpha diversities in microbiotas. Only those taxa were considered to 
be positive that had at least support of 50 reads; all others were discarded. Data were processed in python 3.7 
with scikit-bio version 0.5.5. Bray–Curtis distance measure was used for assessing the beta-diversities of the 
microbiota and principal component analysis (PCA) for visualizing microbiotas. Differential abundance test-
ing was done using Wilcoxon rank-sum test (in tissue-urine pairs) and  PERMANOVA41 was used to determine 
compositional similarities.
Data availability
The datasets generated during the current study are available in the Short Read Archive (SRA) under accession 
number: PRJNA604455.
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